Adverse Effects of ATG/ALG Therapy in Aplastic Anemia
Recruiting
Observational Study
Aplastic Anaemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective, single-center, observational cohort study aims to systematically observe and describe the clinical characteristics of adverse reactions in patients with aplastic anemia undergoing ATG (Anti-Thymocyte Globulin) /ALG (Anti-Lymphocyte Globulin) treatment, providing a data foundation for the development of relevant management strategies. This study plans to enroll 200 aplastic anemia…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Meet the diagnostic criteria for aplastic anemia (Camitta criteria);
* Receiving ATG/ALG immunosuppressive therapy for the first time;
Exclusion Criteria:
* Previously received hematopoietic stem cell transplantation;
* Aplastic anemia patients receiving ATG/ALG as part of t…
Contacts